New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

by ElsevierCredit: Unsplash/CC0 Public DomainTransportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs th
Oncology February 23,2024
Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

by ElsevierCredit: Unsplash/CC0 Public DomainTransportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs th
Oncology February 23,2024
New bacterial therapy approach to treat lung cancer

New bacterial therapy approach to treat lung cancer

by Holly Evarts,Columbia University School of Engineering and Applied ScienceFluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular grow
Oncology February 23,2024
New bacterial therapy approach to treat lung cancer

New bacterial therapy approach to treat lung cancer

by Holly Evarts,Columbia University School of Engineering and Applied ScienceFluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular grow
Oncology February 23,2024
Study uncovers trends in the global burden of tracheal, bronchus, and lung cancer

Study uncovers trends in the global burden of tracheal, bronchus, and lung cancer

by Cactus CommunicationsAge-specific rates of incidence, mortality, and DALY for TBL cancer by sex globally in 2019. A–C: Age-specific incidence rates in the whole population (A), males (B), and femal
Oncology February 23,2024
Study uncovers trends in the global burden of tracheal, bronchus, and lung cancer

Study uncovers trends in the global burden of tracheal, bronchus, and lung cancer

by Cactus CommunicationsAge-specific rates of incidence, mortality, and DALY for TBL cancer by sex globally in 2019. A–C: Age-specific incidence rates in the whole population (A), males (B), and femal
Oncology February 23,2024
Discovery could lead to new drugs to block protein that fuels bowel cancer

Discovery could lead to new drugs to block protein that fuels bowel cancer

by Institute of Cancer ResearchUsing cryo-electron microscopy, researchers obtained a detailed map (shown in orange) of the chain-like tankyrase structure. By interpreting this map and reconstruc
Oncology February 23,2024
Discovery could lead to new drugs to block protein that fuels bowel cancer

Discovery could lead to new drugs to block protein that fuels bowel cancer

by Institute of Cancer ResearchUsing cryo-electron microscopy, researchers obtained a detailed map (shown in orange) of the chain-like tankyrase structure. By interpreting this map and reconstruc
Oncology February 23,2024
Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms

Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms

by Lori SolomonA six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to
Oncology February 23,2024
Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms

Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms

by Lori SolomonA six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to
Oncology February 23,2024
A new therapeutic strategy to improve treatment of aggressive endometrial cancer

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus
Oncology February 23,2024
A new therapeutic strategy to improve treatment of aggressive endometrial cancer

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus
Oncology February 23,2024
Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

by University of California, Los AngelesSingle-cell sequencing reveals the diverse functional states of glioma cells post-radiation.aUMAP plot of cell clusters from control (0 Gy) and
Oncology February 23,2024
Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

by University of California, Los AngelesSingle-cell sequencing reveals the diverse functional states of glioma cells post-radiation.aUMAP plot of cell clusters from control (0 Gy) and
Oncology February 23,2024
Study connects research scientists with the communities they serve

Study connects research scientists with the communities they serve

by Mark Anthony Febbo,University of ArizonaJoann Sweasy, PhD, director of the UArizona Cancer Center, speaks at a Scientific Café event at Rollies Mexican Patio restaurant. Credit: UArizona Heal
Oncology February 23,2024
Study connects research scientists with the communities they serve

Study connects research scientists with the communities they serve

by Mark Anthony Febbo,University of ArizonaJoann Sweasy, PhD, director of the UArizona Cancer Center, speaks at a Scientific Café event at Rollies Mexican Patio restaurant. Credit: UArizona Heal
Oncology February 23,2024
Skin cancer-related mutations higher in the UK than Singapore, new study shows

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred
Oncology February 23,2024
Skin cancer-related mutations higher in the UK than Singapore, new study shows

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred
Oncology February 23,2024
Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta
Oncology February 23,2024
Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta
Oncology February 23,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com